Phase II, Multicenter, Randomized Trial of Docetaxel Plus Prednisone With or Without Cediranib in Men With Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer
Oncologist - United States
doi 10.1634/theoncologist.2019-0331
Full Text
Open PDFAbstract
Available in full text
Date
May 31, 2019
Authors
Publisher
Alphamed Press